A research team has identified a critical event driving tumor growth in a type of medulloblastoma -- and a way to block it.

The discovery and development of GLP-1 receptor agonists for type 2 diabetes and obesity is a bench-to-bedside success story.1 Multiple GLP-1 receptor agonists are now in clinical use, such as ...

Researchers from the University of Illinois have identified a key process coordinating liver maturation and polyploidization, ...

Cannovation Clinical Research Partners Psychedelic Division We are pleased to announce the new changes within our organization as of ...

Long-term partnerships between banks and fintechs are the real future of financial services. Pharmaceutical firms' ...

NIH has an historic opportunity to transform post-viral illness research by bringing ME/CFS into its long Covid RECOVER ...

Sarah Anderson, oncology strategy lead director, Novotech, discusses the significance of triple-negative breast cancer ...

AI was a key theme at OCT Medical Devices 2025, yet human sensibility appears to be the true differentiator in clinical trial ...

Recent advances in immunotherapy have revolutionized the treatment of breast and gynecological cancers, and current ...

We recently published a list of 35 Non-Tech AI Opportunities Amid DeepSeek Selloff. In this article, we are going to take a look at where IQVIA Holdings Inc. (NYSE:IQV) stands against other non-tech ...

In this article, we are going to take a look at where Tenet Healthcare Corporation (NYSE:THC) stands against other non-tech ...

Taking longer to enter the dream phase can disrupt the ability to consolidate memories and interfere with emotion regulation.